SLC2A1 and central nervous system cancer: Emerging evidence implicates palmitoylation in regulating nutrient transporters (e.g., GLUT1) and metabolic enzymes (e.g., ACLY), suggesting its potential role in rewiring glioma metabolism—a dimension meriting dedicated metabolomic studies.